Rise in R &D activities for the development of combination drugs is primarily fueling the growth of the cephalosporin Drugs market
The cephalosporin is a type of antibiotics, more commonly known as "cephaloporins", are a group of beta-lactams antibiotics originally discovered in the fungus Acremonium, also known as "sea salts". They were first used in dialysis treatment for eliminating or reducing blood pressure. This was followed by the development of other applications such as for the treatment of infections resistant toazobic antibiotics (bacteria) and Staphylococcus aureus (a bacterium that causes strep throat) An increase in prevalence of the infectious disease is a key factor driving the growth of the cephalosporin drugs market. It is majorly used to treat diseases such as pneumonia, strep throat, gonorrhea, skin infections, staph infections, bronchitis, tonsillitis, otitis media, and others. The rise in R &D activities for the development of combination drugs and growing funding for the development of antibiotics is also projected to foster the growth of the cephalosporin drugs m...